Abstract

The formulation of this research problem is how the dividend policy, stock price, the value of the company and leverage at Sub Sector of Pharmaceutical company listed in Indonesia Stock Exchange are described, and how the influence of dividend policy and stock price to the value of the company with leverage as moderating variable in Sub Sector of Pharmaceutical company listed in Indonesia Stock Exchange simultaneously or partially. The research method used in this paper is library research. The Object is a Sub-Sector of Pharmaceutical Company listed in the Indonesia Stock Exchange from 2014 to 2016 which published its audited financial statements successively during the year of research and has never experienced a negative net income position and consistently distributed dividends during the research year, totaling of 5 companies. The data used is qualitative and quantitative data, and data collection techniques by way of documentation. The technique of data analysis uses classical assumption, qualitative and quantitative descriptive analysis. The results of the study can be summarized as follows: 1) There are 5 years of companies whose dividend policy is below average, there are 4 years of companies whose stock price is below the average and 3 years of companies whose value is below average, 2) Results regression testing is Y = 1,702 + 1,211 X1 + 1,989 X2 which can be interpreted that there is positive influence between dividend policy and stock price to the value of the Sub Sector of Pharmaceutical company listed in Indonesian Stock Exchange period 2014 until 2016. The strength of relationship of the three variables is medium (r = 0,597). The coefficient of determination is 35.6%, and the remaining 64.4% is explained by other factors. From the results of processing and data calculation, the author concludes that the dividend policy and stock price affect the value of the company in Sub-Sector of Pharmaceutical company listed in the Indonesia Stock Exchange simultaneously or partially and dividend policy and stock price affect the value of the company with leverage as a moderating variable at the Pharmaceutical Sub-sector listed in the Indonesia Stock Exchange simultaneously or partially. Therefore, investors and potential investors should pay attention to the dividend policy and stock price before investing because they are very influential in determining the value of the company and investors and potential investors should pay attention to internal and external factors of the company.

Highlights

  • Investors measure the performance of the company based on the ability of the company in managing resources owned to generate profits so that the value of the company will rise

  • There are many companies listed in the Indonesia Stock Exchange with varying types of operations, the author limits the study only to companies that are relatively similar in the Sub-Sector of Pharmaceutical company

  • From the results of research, the average dividend policy on Sub-Sector of Pharmaceutical Company Listed in Indonesia Stock Exchange 2014 - 2016 is at 0.480

Read more

Summary

Introduction

Investors measure the performance of the company based on the ability of the company in managing resources owned to generate profits so that the value of the company will rise. With the fluctuation of the value of the company, the author is interested to examine the influence of other variables such as dividend policy and stock price. There are many companies listed in the Indonesia Stock Exchange with varying types of operations, the author limits the study only to companies that are relatively similar in the Sub-Sector of Pharmaceutical company. The author conducted a study entitled "Influence of Dividend Policy and Stock Price to the Value of the Company in Sub Sector of Pharmaceutical Company Listed in Indonesia Stock Exchange."

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.